Finally, OPN may be considered as diagnostic and prognostic biomarker of AKI as well as biomolecule with potential for differential diagnosis in patients with cirrhosis; however, further studies in this subgroup may be crucial to define appropriate cutoffs and potential interfering factors, which may be associated with liver dysfunction. The gene discussed is SPP1; the disease is Cirrhosis.